Skip to main content

Skyrizi Prices, Coupons and Patient Assistance Programs

Skyrizi (risankizumab) is a member of the interleukin inhibitors drug class and is commonly used for Crohn's Disease, Plaque Psoriasis, Psoriasis, and others.

The cost for Skyrizi intravenous solution (rzaa 60 mg/mL) is around $10,335 for a supply of 10 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Skyrizi prices

Intravenous Solution

Quantity Per unit Price
10 milliliters $1,033.51 $10,335.13

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Subcutaneous Solution

Quantity Per unit Price
1 milliliter $22,140.78 $22,140.78

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity Per unit Price
1.2 milliliters $18,450.65 $22,140.78

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity Per unit Price
2.4 milliliters $9,225.33 $22,140.78

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Skyrizi Coupons, Copay Cards and Rebates

Skyrizi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Skyrizi Complete Savings Card

Eligible commercially insured patients may pay as little as $5 per dose; annual maximum savings of $14,000 per calendar year; for additional information contact the program at 866-759-7494.

Applies to:
Skyrizi
Number of uses:
Per prescription per calendar year

Form more information phone: 866-759-7494 or Visit website

Skyrizi Complete Savings Card Rebate

Eligible commercially insured patients may submit a rebate request if unable to use the Savings Card at the pharmacy; patient must pay in full for their dose in order to submit a rebate request; rebate may be submitted via fax, online or phone app; for additional information contact the program at 866-759-7494.

Applies to:
Skyrizi
Number of uses:
One rebate per prescription fill

Form more information phone: 866-759-7494 or Visit website

Skyrizi Medicare Part D Extra Help Subsidy

Patients who have Medicare Part D coverage may apply for the program and if accepted may pay no more than $9.85 per prescription; contact the program directly for questions or to sign-up.

Applies to:
Skyrizi
Number of uses:
Per prescription until program expires

Form more information phone: 800-772-1213 or Visit website

Patient Assistance & Copay Programs for Skyrizi

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Skyrizi (risankizumab-rzaa) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: myAbbVie Assist for Skyrizi

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. Not applicable
  4. Must reside in the US and be under the direct care of a US physician
  5. Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
Applicable drugs:
  • Skyrizi (risankizumab-rzaa) Injection; Subcutaneous

More information please phone: 800-222-6885 Visit Website

Provider: Skyrizi Complete Sharps Disposal Program

Eligibility requirements:
  1. Not specified
  2. Not Required
  3. Not specified
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Patient enrolls to receive a free sharps container.
Applicable drugs:
  • Skyrizi (container for skyrizi) Disposal Container

More information please phone: 866-759-7494 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.